FACE-Q皮肤癌模块用于测量面部皮肤癌术后患者报告结局
本研究对FACE-Q皮肤癌模块进行心理测量学验证,该模块包含五个量表,评估面部外观满意度、瘢痕评价、癌症担忧、外观相关心理社会困扰及信息满意度。334例患者中209例纳入(应答率62.6%),Rasch分析将77个条目精简至41个,信度高(PSI和Cronbach's α≥0.90),癌症担忧量表显示反应性(P=0.004)。
要点
- FACE-Q皮肤癌模块经Rasch模型验证,条目从77个精简至41个,信度高(PSI和Cronbach's α≥0.90)。
- 量表存在较高的地板和天花板效应,可能限制对轻微外观或担忧受损患者的区分能力。
- 癌症担忧量表显示反应性(P=0.004),可用于临床实践和更大规模验证研究。
核心结论
- FACE-Q皮肤癌模块满足Rasch模型要求,提供线性化测量。
- 区分轻微外观或担忧受损患者的能力可能是该模块的局限性。
- 该量表可用于更大规模验证研究、临床实践和研究。
研究设计与样本
- 心理测量学验证研究,纳入334例患者中的209例(应答率62.6%)。
- 参与者因面部基底细胞癌或鳞状细胞癌接受Mohs手术,或早期面部黑色素瘤切除。
- 队列1在术前和术后接受量表评估;队列2在术后两个时间点接受量表以评估重测信度。
- 采用Rasch测量理论筛选条目,并分析信度、效度、地板和天花板效应及反应性。
主要发现
- Rasch分析将总条目从77个减少至41个。
- 所有条目阈值有序且心理测量拟合良好。
- 信度高(Person separation index和Cronbach's α≥0.90)。
- 测量相似构念的量表之间存在相关性。
- 量表显示较高的地板和天花板效应。
关键数值与推荐
- 信度:Person separation index和Cronbach's α≥0.90。
- 反应性:癌症担忧量表P=0.004。
- 条目数从77减少至41。
临床怎么用
- FACE-Q皮肤癌模块可用于临床实践和研究。
- 该模块可用于更大规模验证研究。
局限性
- 区分轻微外观或担忧受损患者的能力可能是该模块的局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The patient's perspective of their facial scar after skin cancer surgery influences perception of care and quality of life (QoL). Appearance satisfaction after surgery is also an important but often overlooked treatment outcome. OBJECTIVES: To report the psychometric validation of the FACE-Q Skin Cancer Module consisting of five scales, measuring appearance satisfaction (Satisfaction with Facial Appearance, Appraisal of Scars), QoL (Cancer Worry, Appearance-related Psychosocial Distress) and the patient experience (Satisfaction with Information: Appearance). METHODS: Participants underwent Mohs surgery for facial basal or squamous cell carcinoma or excision of early facial melanoma. Cohort 1 received a set of scales before and after surgery. Cohort 2 received the scales on two occasions in the postoperative period for test-retest reliability. Rasch measurement theory was used to select (item-reduce) the most clinically meaningful items for the scales. Reliability, validity, floor and ceiling effects and responsiveness were also analysed. RESULTS: Of 334 patients, 209 (response rate 62·6%) were included. Rasch analysis reduced the total scale items from 77 to 41. All items had ordered thresholds and good psychometric fit. Reliability was high (Person separation index and Cronbach's α ≥ 0·90) and scales measuring similar constructs were correlated. High floor and ceiling effects were seen for the scales. The Cancer Worry scale demonstrated responsiveness (P = 0·004). CONCLUSIONS: The FACE-Q Skin Cancer Module meet the requirements of the Rasch model providing linearized measurement. Discriminating between patients with minimal appearance or worry impairment may be a limitation. The scales can be used for larger validation studies, clinical practice and research.
引用
- Lee EH, Klassen AF, Cano SJ, et al. FACE-Q Skin Cancer Module for measuring patient-reported outcomes following facial skin cancer surgery. Br J Dermatol. 2018. PMID: 29654700. doi:10.1111/bjd.16671
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。